Pentwater Capital Management’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-181,290
Closed -$480K 88
2025
Q3
$480K Hold
181,290
﹤0.01% 100
2025
Q2
$178K Hold
181,290
﹤0.01% 94
2025
Q1
$261K Hold
181,290
﹤0.01% 101
2024
Q4
$399K Hold
181,290
﹤0.01% 87
2024
Q3
$299K Hold
181,290
﹤0.01% 88
2024
Q2
$402K Buy
+181,290
New +$426K 0.01% 89
2023
Q3
Sell
-181,290
Closed -$252K 123
2023
Q2
$252K Hold
181,290
﹤0.01% 124
2023
Q1
$288K Buy
181,290
+41,163
+29% +$212K ﹤0.01% 135
2022
Q4
$873K Sell
140,127
-114,965
-45% -$822K 0.02% 102
2022
Q3
$1.71M Sell
255,092
-68,610
-21% -$471K 0.02% 113
2022
Q2
$2.06M Sell
323,702
-34,304
-10% -$195K 0.02% 127
2022
Q1
$1.66M Sell
358,006
-4,574
-1% -$19.6K 0.02% 122
2021
Q4
$1.81M Buy
+362,580
New +$2.9M 0.02% 140
2021
Q3
Sell
-289,183
Closed -$6.12M 250
2021
Q2
$6.12M Sell
289,183
-318,397
-52% -$7.67M 0.05% 91
2021
Q1
$17M Buy
607,580
+110,000
+22% +$3.25M 0.16% 67
2020
Q4
$12.9M Sell
497,580
-1,671,442
-77% -$50.1M 0.16% 53
2020
Q3
$80.6M Sell
2,169,022
-73,500
-3% -$2.91M 1.04% 22
2020
Q2
$115M Sell
2,242,522
-70,500
-3% -$2.95M 2.05% 13
2020
Q1
$72.9M Buy
2,313,022
+59,761
+3% +$3.15M 1.2% 25
2019
Q4
$134M Sell
2,253,261
-225,000
-9% -$10.1M 2.2% 12
2019
Q3
$90.9M Buy
2,478,261
+42,761
+2% +$1.69M 1.42% 15
2019
Q2
$113M Sell
2,435,500
-41,000
-2% -$1.93M 1.22% 18
2019
Q1
$99.4M Sell
2,476,500
-10,800
-0.4% -$484K 1.25% 19
2018
Q4
$114M Buy
2,487,300
+135,800
+6% +$6.54M 0.98% 16
2018
Q3
$104M Sell
2,351,500
-112,500
-5% -$5.16M 0.88% 17
2018
Q2
$96.6M Buy
2,464,000
+153,500
+7% +$7.76M 0.71% 24
2018
Q1
$167M Buy
2,310,500
+381,269
+20% +$28M 1.18% 24
2017
Q4
$127M Sell
1,929,231
-313,969
-14% -$16.9M 0.84% 24
2017
Q3
$112M Buy
2,243,200
+255,200
+13% +$12.3M 0.96% 21
2017
Q2
$92M Buy
1,988,000
+151,800
+8% +$5.58M 0.84% 27
2017
Q1
$64.8M Buy
1,836,200
+8,200
+0.4% +$188K 0.79% 28
2016
Q4
$22.9M Buy
1,828,000
+292,000
+19% +$3.48M 0.29% 48
2016
Q3
$21.3M Buy
1,536,000
+18,000
+1% +$204K 0.2% 55
2016
Q2
$15M Buy
1,518,000
+94,000
+7% +$1.56M 0.2% 49
2016
Q1
$24.1M Sell
1,424,000
-15,000
-1% -$241K 0.18% 44
2015
Q4
$32M Sell
1,439,000
-11,000
-0.8% -$278K 0.22% 45
2015
Q3
$34.2M Sell
1,450,000
-68,000
-4% -$4.27M 0.3% 47
2015
Q2
$124M Buy
1,518,000
+222,000
+17% +$21.7M 0.66% 32
2015
Q1
$120M Sell
1,296,000
-174,000
-12% -$11.2M 0.9% 27
2014
Q4
$59.4M Buy
1,470,000
+480,000
+48% +$14.7M 0.42% 46
2014
Q3
$24.2M Sell
990,000
-10,000
-1% -$159K 0.23% 68
2014
Q2
$15.8M Buy
1,000,000
+113,776
+13% +$1.64M 0.17% 61
2014
Q1
$13.4M Buy
886,224
+244,324
+38% +$3.79M 0.36% 41
2013
Q4
$8.82M Buy
641,900
+210,846
+49% +$3.07M 0.25% 63
2013
Q3
$8.13M Buy
+431,054
New +$7.24M 0.23% 62

Other funds holding ESPR